Vendor, Houston, TX
The Univeristy of Texas M.D. Anderson Cancer Center
UEI S3GMKS8ELA16, CAGE 0KD38
40 awards and $37,186,963 obligated between January 8, 2024 and September 10, 2026, 65% under full and open competition, against 2.0 offers on average where reported. 12 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| Health Resources and Services Administration | $26,737,056 |
| National Institutes of Health | $7,024,628 |
| Food and Drug Administration | $2,317,682 |
| Department of Veterans Affairs | $1,107,598 |
Industries
NAICS on the awards, by dollars.
| Blood and Organ BanksNAICS 621991 | $26,737,056 |
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $4,630,116 |
| Veterinary ServicesNAICS 541940 | $4,131,465 |
| All Other Professional, Scientific, and Technical ServicesNAICS 541990 | $1,104,835 |
| All Other Animal ProductionNAICS 112990 | $950,540 |
| Electronic and Precision Equipment Repair and MaintenanceNAICS 811210 | $2,763 |
| Professional, Scientific, and Technical ServicesNAICS 541711 | $0 |
| Research and Development in the Social Sciences and HumanitiesNAICS 541720 | -$142,426 |
| Professional, Scientific, and Technical ServicesNAICS 541712 | -$227,385 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 26 |
| Competed Under SAP | 6 |
| Not Competed | 5 |
| Not Competed Under SAP | 3 |
| Delivery Order | 21 |
| Definitive Contract | 8 |
| Purchase Order | 8 |
Hear when The Univeristy of Texas M.D. Anderson Cancer Center wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts The Univeristy of Texas M.D. Anderson Cancer Center holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 8
- Obligated so far
- $4,276,623
- Soonest
- December 19, 2026
The 8 contracts, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling blood and organ banks to Health Resources and Services Administration, by dollars.
| Lifesouth Community Blood Centers Inc.Gainesville, FL | $3,530,480 |
| The Abraham J & Phyllis Katz Cord Blood FoundationWarrensville Heights, OH | $2,823,552 |
| BBG Advanced TherapiesSan Antonio, TX | $0 |
| SSM Cardinal Glennon Children'S HospitalSaint Louis, MO | $0 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Operation and Maintenance of the Chimpanzee Care Center (CCC)
National Institutes of Health, National Institutes of Health Olao
Award noticeNAICS 541940Houston, TX75N98026C00052Awarded to The Univeristy of Texas M.D. Anderson Cancer Center for $7,639,366
Posted Sep 2 - Operation and Maintenance of the Chimpanzee Care Center (CCC)
National Institutes of Health, National Institutes of Health Olao
JustificationNAICS 541940Houston, TX75N97021C00001Awarded to The Univeristy of Texas M.D. Anderson Cancer Center
Posted Jun 8 - Medical Physics Peer Review Services
Department of Veterans Affairs, 245-Network Contract Office 5
Award noticeNAICS 541990Houston, TX36C24524Q0548Awarded to The Univeristy of Texas M.D. Anderson Cancer Center for $1,165,320
Posted Oct 2, 20243 publications - PREVENT IDIQ MATO RFP
National Institutes of Health, NIH NCI
Award noticeNAICS 541714Houston, TX75N91024D00004Awarded to The Univeristy of Texas M.D. Anderson Cancer Center for $149,995,000
Posted Jan 31, 20242 publications
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75R60219C00004Definitive Contract, May 8, 2024, Full and Open Competition, 6 offers | HRSA HeadquartersHealth Resources and Services Administration | National Cord Blood InventoryNAICS 621991, PSC Q508 | $26,737,056 |
| 75N97021C00001Definitive Contract, January 8, 2024, Not Competed, 1 offersSolicitation | National Institutes of Health NLMNational Institutes of Health | Operation and Maintenance of the Chimpanzee Care Center (Ccc)NAICS 541940, PSC R499 | $2,552,886 |
| 75N98026C00052Definitive Contract, August 31, 2026, Not Competed, 1 offersSolicitation | National Institutes of Health OlaoNational Institutes of Health | Operation and Maintenance of the Chimpanzee Care Center (Ccc)NAICS 541940, PSC R499 | $1,578,579 |
| 75N91025F00001Delivery Order, September 22, 2025, Full and Open Competition, 1 offers | NIH NCINational Institutes of Health | Project Title: LOW-DOSE Erlotinib and Mesalamine for Prevention of Colitis-Associated Colorectal Cancer (Cac)NAICS 541714, PSC AN12 | $1,324,125 |
| 75F40125C00075Definitive Contract, September 16, 2025, Competed Under SAP, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | BAA-MD Anderson-Statistical Designs and Considerations for Dose Optimization Fy25c1fp6NAICS 541714, PSC AJ11 | $1,184,156 |
| 36C24524P0903Purchase Order, September 27, 2024, Not Competed Under SAP, 1 offersSolicitation | 245-Network Contract Office 5Department of Veterans Affairs | Med Physics Peer Review ServicesNAICS 541990, PSC Q527 | $1,147,040 |
| 75F40126C00055Definitive Contract, August 6, 2026, Competed Under SAP, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | BAA Fy26c1fp7 MD Anderson Oncology Center for Excellence (Oce), Evaluating Bayesian Effective Sample Size and Decision Criteria for PediatriNAICS 541714, PSC AJ11 | $752,304 |
| 75N91023F00003Delivery Order, March 12, 2024, Full and Open Competition, 1 offers | NIH NCINational Institutes of Health | Base IDIQ Title: Prevent Preclinical Drug Development Program: Preclinical Efficacy & Intermediate Biomarkers Targeting the A2B Adenosine ReNAICS 541714, PSC AN12 | $678,909 |
| 75N91024F00002Delivery Order, September 11, 2024, Full and Open Competition, 1 offers | NIH NCINational Institutes of Health | Time-Restricted Feeding for Pancreatic Cancer PreventionNAICS 541714, PSC AN12 | $551,730 |
| 75F40126P00275Purchase Order, August 31, 2026, Competed Under SAP, 2 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Bordetella-Free Baboons for Pertussis Infection and Vaccination StudiesNAICS 112990, PSC 8820 | $368,627 |
| 75F40126P00158Purchase Order, August 5, 2026, Competed Under SAP, 2 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Bordetella-Free Baboon StudyNAICS 112990, PSC 8820 | $206,192 |
| 75N91023F00002Delivery Order, February 7, 2024, Full and Open Competition, 1 offers | NIH NCINational Institutes of Health | Targeting DKK1 with a Dna Vaccine to Prevent Development of Multiple MyelomaNAICS 541714, PSC AN12 | $147,621 |
| 75N98024F00001Delivery Order, January 16, 2024, Full and Open Competition | National Institutes of Health OlaoNational Institutes of Health | Per Diem and Testing Cost for the Niaid Owl Colony Iaw the Contract SowNAICS 112990, PSC 8820 | $145,000 |
| 75N98025F00003Delivery Order, September 16, 2025, Full and Open Competition | National Institutes of Health OlaoNational Institutes of Health | V105: NON-HUMAN Primate AcquisitionNAICS 112990, PSC 8820 | $123,000 |
| 75N98025F00002Delivery Order, February 3, 2025, Full and Open Competition | National Institutes of Health OlaoNational Institutes of Health | Per Diem and Testing Cost for the Niaid Aotus NHP ColonyNAICS 112990, PSC 8820 | $115,000 |
| 75N98025F00001Delivery Order, December 12, 2024, Full and Open Competition | National Institutes of Health OlaoNational Institutes of Health | Squirrel Monkey, Bolivian, Mixed Gender, Spf, Iaw Contract Sow and RFQ N73NAICS 112990, PSC 8820 | $40,865 |
| 75N98024F00002Delivery Order, July 16, 2024, Full and Open Competition | National Institutes of Health OlaoNational Institutes of Health | Squirrel Monkeys, Mixed Gender, SPF Iaw with Contract Sow and Rfq- N73-BNAICS 112990, PSC 8820 | $33,435 |
| 36C25726P0378Purchase Order, April 30, 2026, Not Competed Under SAP, 1 offers | 257-Network Contract Office 17Department of Veterans Affairs | Ratification for Calibration ServicesNAICS 811210, PSC J065 | $2,763 |
| 75N91022F00001Delivery Order, March 11, 2025, Full and Open Competition, 1 offers | NIH NCINational Institutes of Health | Prevent Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers Task Order Title: Targeting tNAICS 541714, PSC AN12 | $0 |
| 75N91022F00002Delivery Order, March 5, 2025, Full and Open Competition, 1 offers | NIH NCINational Institutes of Health | Prevent Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoints Biomarkers Task Order Title: Targeting NAICS 541714, PSC AN12 | $0 |
| 75N91023F00001Delivery Order, March 11, 2025, Full and Open Competition, 1 offers | NIH NCINational Institutes of Health | To Title: Further Development of Ipsc-Based Vaccine for Colon Cancer Prevention Base IDIQ Title: Prevent Cancer Preclinical Drug DevelopmentNAICS 541714, PSC AN12 | $0 |
| 75N91023P00541Purchase Order, June 20, 2024, Competed Under SAP, 5 offers | NIH NCINational Institutes of Health | US Pediatric Proton and Photon Therapy Cohort AwardNAICS 541990, PSC B529 | $0 |
| HHSN268200900039CDefinitive Contract, November 13, 2024, Not Competed, 1 offers | National Institutes of Health NhlbiNational Institutes of Health | Closeout ModificationNAICS 541711, PSC AN11 | $0 |
| 75N91019D00021January 21, 2025, Full and Open Competition, 4 offers | NIH NCINational Institutes of Health | Preclinical Efficacy and Intermediate BiomarkersNAICS 541714, PSC AN12 | $0 |
| 75N91024D00004January 24, 2024, Full and Open Competition, 9 offersSolicitation | NIH NCINational Institutes of Health | Preclinical Efficacy & Intermediate Endpoint Biomarkers IDIQ Contract in Support of the Prevent Cancer Preclinical Drug Development ProgramNAICS 541714, PSC AN12 | $0 |
| 75N98021D00018July 24, 2024, Full and Open Competition, 4 offers | National Institutes of Health OlaoNational Institutes of Health | NON-HUMAN Primate Acquisition, Testing, Transportation and HousingNAICS 112990, PSC 8820 | $0 |
| HHSN26100008Delivery Order, December 12, 2024, Full and Open Competition, 1 offers | NIH NCINational Institutes of Health | Alternative Dosing of Exemestane in Postmenopausal Women with Stage 0-II Er-Positive Breast Cancer: a Randomized Presurgical TrialNAICS 541712, PSC AN12 | -$598 |
| 75N91020F00001Delivery Order, April 18, 2024, Full and Open Competition, 1 offers | NIH NCINational Institutes of Health | Base: Prevent Preclinical Drug Development Program: Preclinical Efficacy & Intermediate Biomarkers Task Order: Targeting Stat3 to Prevent HeNAICS 541714, PSC AN12 | -$2,676 |
| 75N91021F00002Delivery Order, August 21, 2024, Full and Open Competition, 1 offers | NIH NCINational Institutes of Health | Base Contract Title: Prevent Preclinical Drug Development Program: Preclinical Efficacy & Intermediate Biomarkers Task Order Title: TargetinNAICS 541714, PSC AN12 | -$2,701 |
| 75N91021F00003Delivery Order, February 26, 2024, Full and Open Competition, 1 offers | NIH NCINational Institutes of Health | Base IDIQ Title: Prevent Preclinical Drug Development Program: Preclinical Efficacy & Intermediate Biomarkers Task Order Title: Evaluation oNAICS 541714, PSC AN12 | -$3,352 |
| 75N91019F00129Delivery Order, June 27, 2024, Full and Open Competition, 5 offers | NIH NCINational Institutes of Health | Other Functions - Cancer Prevention Agent Development Program: Early Phase Clinical ResearchNAICS 541712, PSC AN12 | -$7,043 |
| HHSN26100009Delivery Order, May 9, 2024, Full and Open Competition, 7 offers | NIH NCINational Institutes of Health | Vadis Trial: Phase II Trial of E75 Peptide Vaccine in Women with Dcis of the BreastNAICS 541712, PSC AN12 | -$20,792 |
| 75F40123P00335Purchase Order, June 26, 2024, Not Competed Under SAP, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | The Purpose of This Modification Is to Modify the Subject Contract to Extend the Current Contract to 12/31/2024.NAICS 541720, PSC 8820 | -$21,017 |
| 75F40121P00534Purchase Order, February 24, 2026, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | EO14042 Merkelomv-Ap Study (Baboons)NAICS 112990, PSC 8820 | -$22,608 |
| 75F40120P00519Purchase Order, January 20, 2026, Competed Under SAP, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Duration of Pertussis Immunity in Baboons StudyNAICS 112990, PSC R425 | -$28,562 |
| HHSN26300005Delivery Order, January 13, 2025, Full and Open Competition | National Institutes of Health OlaoNational Institutes of Health | Squirrel Monkeys, Bolivia, Either Gender, Greater Than 700 Gram, Established Pairs Preferred, SPF (Ref. N1)NAICS 112990, PSC 8820 | -$30,408 |
| HHSN26100012Delivery Order, April 10, 2024, Full and Open Competition, 1 offers | NIH NCINational Institutes of Health | Topical Bexarotene in Women at High Risk for Breast CancerNAICS 541712, PSC AN12 | -$33,929 |
| 36C24521C0180Definitive Contract, November 1, 2024, Not Competed, 1 offers | 245-Network Contract Office 5Department of Veterans Affairs | Deob and Close Out Oy 1 Po 132C20064 Peer Review of Radiation TherapyNAICS 541990, PSC Q527 | -$42,205 |
| 75F40121C00180Definitive Contract, April 21, 2025, Not Competed, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Immunogenicity Study in Baboons Following Vaccination with Experimental Acellular Pertussis Vaccines.NAICS 541720, PSC B542 | -$121,409 |
| HHSN26100011Delivery Order, June 25, 2024, Full and Open Competition, 1 offers | NIH NCINational Institutes of Health | A Randomized, Double-Blind, Placebo-Controlled Study of 4-Hydroxytamoxifen Topical Gel in Women with Mammographically Dense BreastsNAICS 541712, PSC AN12 | -$165,023 |
- Product and service codes
- Q508 Hematology & OncologyR499 Other Professional ServicesAN12 Health R&D Services; Health Care Services; Applied ResearchAJ11 General Science And Technology R&D Services; General Science And Technology; Basic ResearchQ527 Nuclear Medicine8820 Live Animals, Not Raised for Food
- Transactions
- 96 across 40 awards